Bedel Financial Consulting, Inc. Becton Dickinson & CO Transaction History

Bedel Financial Consulting, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$234.74 - $275.42 $42,722 - $50,126	-182 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$243.64 - $270.48 $10,720 - $11,901	-44 Reduced 19.47%	182 $48,000
Q4 2021 Jan 11, 2022	BUY	$230.08 - $250.94 $9,433 - $10,288	41 Added 22.16%	226 $57,000
Q3 2021 Oct 12, 2021	BUY	$232.72 - $256.47 $698 - $769	3 Added 1.65%	185 $45,000
Q1 2018 May 03, 2018	BUY	$205.46 - $240.27 $37,393 - $43,729	182 New	182 $39,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.